España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Intelgenx Technologies
IGXT
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1090
NaN%
After Hours: Nov 1, 8:42 AM EDT
Get Report
Comment
Intelgenx Technologies (IGXT) Forecast
News
Earnings
Intelgenx Technologies (IGXT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Intelgenx Technologies (OTC:IGXT) Stock
Intelgenx Technologies Stock (OTC: IGXT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 15, 2024
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Lara Goldstein
Thursday, November 09, 2023
Intelgenx Technologies Q3 EPS $(0.01) Up From...
Benzinga Newsdesk
Monday, November 06, 2023
IntelGenx Announces Co-Development And Commer...
Benzinga Newsdesk
Tuesday, August 15, 2023
IntelGenx Q2 2023: Revenue Decline 67%, Operating Costs Rise, What About Net Loss?
Nicolás Jose Rodriguez
Monday, August 14, 2023
Intelgenx Technologies Q2 EPS $(0.02), Same Y...
Benzinga Newsdesk
Monday, May 15, 2023
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein
Thursday, May 11, 2023
FDA Gives Nod To IntelGenx's Migraine Solution As Revenues Plunge 32%; Q1 Results Report
Nicolás Jose Rodriguez
Intelgenx Technologies Q1 EPS $(0.02), Same Y...
Benzinga Newsdesk
Wednesday, April 05, 2023
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Lara Goldstein
Thursday, March 30, 2023
IntelGenx's Q4 And Full-Year 2022 Financials, 'On The Cusp' Of Rapid Growth?
Lara Goldstein
Intelgenx Technologies Q4 EPS $(0.01) Up From $(0.02) YoY, Sales $173.00K Down From $494.00K YoY
Happy Mohamed
Tuesday, January 31, 2023
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, January 30, 2023
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, January 27, 2023
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, January 26, 2023
Psychedelic Stock Gainers And Losers From January 26, 2023
Benzinga Insights
Wednesday, January 25, 2023
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, January 24, 2023
Psychedelic Stock Gainers And Losers From January 24, 2023
Benzinga Insights
Thursday, January 19, 2023
Psychedelic Stock Gainers And Losers From January 19, 2023
Benzinga Insights
Monday, January 16, 2023
GH Research, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, January 13, 2023
Psychedelic Stock Gainers And Losers From January 13, 2023
Benzinga Insights
Thursday, January 12, 2023
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
Lara Goldstein
Thursday, November 10, 2022
IntelGenx Reports Q3 2022 Financial Results, Management Anticipates Psychedelics Trials In 2023
Nicolás Jose Rodriguez
Intelgenx Technologies Q3 EPS $(0.02) Down Fr...
Benzinga Newsdesk
Thursday, November 03, 2022
New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection
Lara Goldstein
Tuesday, October 25, 2022
Canadian Company's New Version Of Chemo-Induced Pain Treatment Is On FDA Track
Lara Goldstein
Thursday, October 13, 2022
IntelGenx's Collaboration With ATAI Life Scie...
Benzinga Newsdesk
Tuesday, October 04, 2022
Short Volatility Alert: IntelGenx Technologies Corp.
Christopher Sappo
Thursday, August 11, 2022
Intelgenx Technologies Q2 EPS $(0.02), Same Y...
Benzinga Newsdesk
Wednesday, August 03, 2022
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, August 01, 2022
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, July 29, 2022
Psychedelic Stock Gainers And Losers From July 29, 2022
Benzinga Insights
Thursday, June 09, 2022
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, June 08, 2022
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, June 07, 2022
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, June 06, 2022
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, June 03, 2022
Psychedelic Stock Gainers And Losers From June 3, 2022
Benzinga Insights
Thursday, June 02, 2022
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, June 01, 2022
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, May 31, 2022
Psychedelic Stock Gainers And Losers From May 31, 2022
Benzinga Insights
Thursday, May 26, 2022
Psychedelic Stock Gainers And Losers From May 26, 2022
Benzinga Insights
Wednesday, May 25, 2022
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, May 24, 2022
Psychedelic Stock Gainers And Losers From May 24, 2022
Benzinga Insights
Monday, May 23, 2022
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, May 20, 2022
Psychedelic Stock Gainers And Losers From May 20, 2022
Benzinga Insights
Thursday, May 19, 2022
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, May 18, 2022
Cybin, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, May 17, 2022
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, May 16, 2022
Psychedelic Stock Gainers And Losers From May 16, 2022
Benzinga Insights
Wednesday, May 11, 2022
Psychedelic Stock Gainers And Losers From May 11, 2022
Benzinga Insights
Show More
